Top compounds associated with response to XIRP1


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.5
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.019 0.5
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.021 0.5
mRNA GDC-0449 GDSC1000 pan-cancer AAC -0.022 0.5
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.022 0.5
mRNA Lisitinib GDSC1000 pan-cancer AAC -0.021 0.5
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.022 0.5
mRNA KIN001-266 GDSC1000 pan-cancer AAC -0.021 0.5
mRNA BRD-K50799972 CTRPv2 pan-cancer AAC 0.023 0.5
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC -0.032 0.5
Download CSV